{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:52Z","timestamp":1786119232002,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/inf.0b013e318199f609","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T10:33:20Z","timestamp":1242902000000},"page":"S77-S88","source":"Crossref","is-referenced-by-count":82,"title":["Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines"],"prefix":"10.1097","volume":"28","author":[{"given":"Jacek","family":"Wysocki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dutlef","family":"Grunert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Konior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Garcia-Sicilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Knuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Dieussaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ijantimicag.2006.11.031","article-title":"Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region.","volume":"29","author":"Tzanakaki","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"R2-3-20210202","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/IAI.59.4.1231-1238.1991","article-title":"Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains.","volume":"59","author":"Akkoyunlu","year":"1991","journal-title":"Infect Immun"},{"key":"R3-3-20210202","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1128\/IAI.61.11.4546-4552.1993","article-title":"Limited diversity of the protein D gene (hpd) among encapsulated and nonencapsulated Haemophilus influenzae strains.","volume":"61","author":"Janson","year":"1993","journal-title":"Infect Immun"},{"key":"R4-3-20210202","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/JB.175.14.4569-4571.1993","article-title":"Protein D, a putative immunoglobulin D-binding protein produced by Haemophilus influenzae, is glycerophosphodiester phosphodiesterase.","volume":"175","author":"Munson","year":"1993","journal-title":"J Bacteriol"},{"key":"R5-3-20210202","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/IAI.63.2.696-699.1995","article-title":"The gene encoding protein D (hpd) is highly conserved among Haemophilus influenzae type b and nontypeable strains.","volume":"63","author":"Song","year":"1995","journal-title":"Infect Immun"},{"key":"R6-3-20210202","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/IAI.62.11.4848-4854.1994","article-title":"Protein D, the glycerophosphodiester phosphodiesterase from Haemophilus influenzae with affinity for human immunoglobulin D, influences virulence in a rat otitis model.","volume":"62","author":"Janson","year":"1994","journal-title":"Infect Immun"},{"key":"R7-3-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/314921","article-title":"Effects on the ciliated epithelium of protein D-producing and -nonproducing nontypeable Haemophilus influenzae in nasopharyngeal tissue cultures.","volume":"180","author":"Janson","year":"1999","journal-title":"J Infect Dis"},{"key":"R8-3-20210202","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00006454-200107000-00004","article-title":"Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.","volume":"20","author":"Kilpi","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R9-3-20210202","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media.","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-3-20210202","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00006454-200105000-00006","article-title":"Bacterial and viral etiology of acute otitis media in Chilean children.","volume":"20","author":"Rosenblut","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R11-3-20210202","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.inf.0000101189.81501.e9","article-title":"Microbiology of otitis media in Costa Rican children, 1999 through 2001.","volume":"22","author":"Arguedas","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R12-3-20210202","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.inf.0000069759.79176.e1","article-title":"Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae?","volume":"22","author":"Leibovitz","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R13-3-20210202","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/01.inf.0000148233.57296.90","article-title":"Haemophilus influenzae: a Significant pathogen in acute otitis media.","volume":"23","author":"Leibovitz","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R14-3-20210202","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.inf.0000168748.92510.45","article-title":"Middle ear fluid Streptococcus pneumoniae serotype distribution in Costa Rican children with otitis media.","volume":"24","author":"Arguedas","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R15-3-20210202","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D provide protection against otitis media caused by both Streptococcus pneumoniae and nontypeable Haemophilus influenzae: a randomized double blind efficacy study.","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R16-3-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children.","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R17-3-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomized trial.","volume":"362","author":"O'Brien","year":"2003","journal-title":"Lancet"},{"key":"R18-3-20210202","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluations and licensure of new pneumococcal conjugate vaccine formulations for use in infants.","volume":"21","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"R19-3-20210202","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0264-410X(03)00025-2","article-title":"Correlates of immunity for pneumococcal conjugate vaccines.","volume":"21","author":"Lee","year":"2003","journal-title":"Vaccine"},{"issue":"annex 2","key":"R20-3-20210202","first-page":"64","article-title":"Pneumococcal conjugate vaccines. Recommendations for production and control of pneumococcal conjugate vaccines.","volume":"927","year":"2005","journal-title":"WHO Tech Rep Ser"},{"key":"R21-3-20210202","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/INF.0b013e31816b4561","article-title":"Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13\u201314 months of age with antibody persistence up to 31 months of age.","volume":"27","author":"Tejedor","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R23-3-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R24-3-20210202","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/CVI.13.3.356-360.2006","article-title":"Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with or without 22F inhibition at low antibody concentrations in pediatric sera.","volume":"13","author":"Henckaerts","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R25-3-20210202","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CDLI.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S.","volume":"2","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"R27-3-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/CDLI.10.6.1019-1024.2003","article-title":"Multi-laboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of. Streptococcus pneumoniae","volume":"10","author":"Romero-Steiner","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R28-3-20210202","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.vaccine.2006.09.029","article-title":"Validation of a routine pneumococcal opsonophagocytosis assays to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.","volume":"25","author":"Henckaerts","year":"2007","journal-title":"Vaccine"},{"key":"R30-3-20210202","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/IAI.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines.","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect Immun"},{"key":"R31-3-20210202","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jama.1994.03520140046036","article-title":"Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.","volume":"272","author":"Granoff","year":"1994","journal-title":"JAMA"},{"key":"R32-3-20210202","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/infdis\/172.5.1268","article-title":"Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy.","volume":"172","author":"Kurikka","year":"1995","journal-title":"J Infect Dis"},{"key":"R33-3-20210202","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R37-3-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200904001-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:42Z","timestamp":1786038642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200904001-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318199f609","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}